Cure8 research brief
Accurate diagnosis and classification affect treatment choices and risks—misdiagnosis can lead to unnecessary immunosuppression, while misclassification can under-recognize severe or proximal disease that needs different management.
Patients and clinicians should know the limits of single tests and the value of combining investigations and reassessing over time.
Clinicians (gastroenterologists, radiologists, pathologists), adult patients with suspected or established Crohn's disease, newly diagnosed patients, and multidisciplinary care teams.
The paper highlights that improvements in imaging and biomarkers have helped earlier diagnosis but also increased false positives; overinterpretation of nonspecific symptoms or isolated endoscopic/histologic findings can lead to overdiagnosis and unnecessary immunosuppression.
Low fecal calprotectin is more reliable for ruling out colonic CD than a high value is for confirming CD; isolated small-bowel disease may be missed by ileocolonoscopy, so cross-sectional imaging or intestinal ultrasound are important to assess proximal/transmural disease.
In TB-endemic areas, intestinal tuberculosis remains a key mimic of Crohn’s and should be carefully considered to avoid inappropriate treatment.
This entry is based on the article abstract (review) from The Turkish Journal of Gastroenterology; it summarizes the authors' discussion and recommendations rather than new primary data. fecal calprotectin and imaging have limitations and regional infectious mimics (eg, intestinal TB) require local consideration.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
IUS with the IBUS‑SAS score may offer a reliable, noninvasive way to monitor Crohn’s disease activity that correlates with clinical scores and biomarkers and aligns well with CT/MRI for most findings.
Noninvasive tools that reliably detect postoperative recurrence could reduce the need for frequent invasive endoscopy and help target earlier intervention for people with Crohn's disease after surgery.
Point-of-care intestinal ultrasound (IUS) showed strong agreement with follow-up tests and often changed management the same day in a New Zealand IBD cohort. Patients and clinicians may be able to use IUS to monitor...
